NM_002661.5:c.2312A>G
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBS1_SupportingBS2
The NM_002661.5(PLCG2):c.2312A>G(p.Gln771Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000336 in 1,607,570 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_002661.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLCG2 | NM_002661.5 | c.2312A>G | p.Gln771Arg | missense_variant | Exon 22 of 33 | ENST00000564138.6 | NP_002652.2 | |
PLCG2 | NM_001425749.1 | c.2312A>G | p.Gln771Arg | missense_variant | Exon 23 of 34 | NP_001412678.1 | ||
PLCG2 | NM_001425750.1 | c.2312A>G | p.Gln771Arg | missense_variant | Exon 22 of 33 | NP_001412679.1 | ||
PLCG2 | NM_001425751.1 | c.2312A>G | p.Gln771Arg | missense_variant | Exon 23 of 34 | NP_001412680.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152200Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000731 AC: 18AN: 246164Hom.: 0 AF XY: 0.0000373 AC XY: 5AN XY: 133908
GnomAD4 exome AF: 0.0000227 AC: 33AN: 1455252Hom.: 0 Cov.: 29 AF XY: 0.0000207 AC XY: 15AN XY: 724060
GnomAD4 genome AF: 0.000138 AC: 21AN: 152318Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74480
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant summary: PLCG2 c.2312A>G (p.Gln771Arg) results in a conservative amino acid change located in the pleckstrin homology domain (IPR001849) of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 7.3e-05 in 246164 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in PLCG2 causing Autoinflammation-PLCG2 Antibody Deficiency-Immune Dysregulation, allowing no conclusion about variant significance. c.2312A>G has been reported in the literature in the heterozygous state in individuals affected with late onset Alzheimer's disease and autoinflammatory syndrome (e.g. Wilke_2024, Olive_2020). These report(s) do not provide unequivocal conclusions about association of the variant with Autoinflammation-PLCG2 Antibody Deficiency-Immune Dysregulation. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 32894242, 38790019). ClinVar contains an entry for this variant (Variation ID: 540099). Based on the evidence outlined above, the variant was classified as uncertain significance. -
Familial cold autoinflammatory syndrome 3 Uncertain:1
This sequence change replaces glutamine, which is neutral and polar, with arginine, which is basic and polar, at codon 771 of the PLCG2 protein (p.Gln771Arg). This variant is present in population databases (rs201803492, gnomAD 0.03%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with PLCG2-related conditions. ClinVar contains an entry for this variant (Variation ID: 540099). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at